Patents Assigned to Ligand Pharmaceutical
  • Thrombopoietin mimetics
    Patent number: 7241783
    Abstract: Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected substituted thiosemicarbazone derivative.
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: July 10, 2007
    Assignees: SmithKline Beecham Corporation, Ligand Pharmaceutical
    Inventors: Kevin J. Duffy, Juan I. Luengo, Stephen G. Miller, Julian Jenkins, Alan T. Price, Antony N. Shaw